UK approves Novavax COVID shot for 12-17 year-olds

Britain approves Novavax COVID shot for 12-17 year-olds Britain's medicines regulator on Friday approved Novavax's COVID-19 vaccine for children aged between 12 and 17 years. Reuters Reuters

...

The mRNA vaccines made by Moderna as well as the partnership between Pfizer-BioNTech are also cleared for use by this age group, the Medicines and Healthcare products Regulatory Agency (MHRA) said. ...